An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
MP-RM-1
Receptor tyrosine kinase
MP-RM-1 is a monoclonal antibody targeting a membrane receptor tyrosine kinase that plays an important role in driving cell growth and invasion in malignancies of epithelial origin, particularly breast cancer and melanoma.
MediaPharma has shown that MP-RM-1 is an effective inhibitor of tumor cell growth in vitro and tumor growth in vivo.
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
